黄芪配伍丹参治疗心脑血管疾病研究进展  

Compatibility of Radix astragali and Radix salviae miltiorrhiae for the treatment of cardio-cerebrovascular system diseases:research advances

作　　者：程敏[1] 梁旭华[1] 赵艳艳[1] 张小斌[1] 陈书存 CHENG Min LIANG Xu-hua ZHAO Yan-yan ZHANG Xiao-bin CHEN Shu-cun(College of Biology Pharmacy and Food Engineering, Shanghto Institute, Shangluo 726000, China Shangluo Chinese Medicine Hospital, Shangluo 726000, China)

机构地区：[1]商洛学院生物医药与食品工程学院,商洛726000 [2]商洛市中医医院,商洛726000

出　　处：《国际药学研究杂志》2017年第6期500-503,共4页Journal of International Pharmaceutical Research

基　　金：陕西省社会发展科技攻关项目(2016SF-369);商洛市科技计划项目(SK2015-34)

摘　　要：心脑血管疾病严重威胁人类生命健康,包括脑梗死、脑出血、脑血管痉挛和心肌梗死等,其发病率、致残率和死亡率均较高。中医认为其基本发病机制是气血失衡,可通过益气活血来改善病证。黄芪配伍丹参适宜于气虚血瘀证,可有效改善心脑血管疾病。本文围绕近年来黄芪、丹参及其配伍在治疗心脑血管疾病方面的应用展开论述,为开发新的抗心脑血管疾病用药提供参考依据。Because of the high morbidity and mortality rate,cardio-cerebrovascular diseases,including cerebral embolism,cerebral hemorrhage,cerebral vasospasm and myocardial infarction,have become main diseases threatening human health. Traditional chinese medicine（TCM）holds that the basic pathogenesis is Qi imbalances,which could be improved by benefiting Qi and promoting blood circulation. The compatibility of Radix astragali and Radix salviae miltiorrhiae are particularly suitable for treating the cardio-cerebrovascular system diseases by improving Qi deficiency and blood stasis. This paper focuses on the application of Radix astragali,Radix s. miltiorrhiae and their compatibility for treating the cardio-cerebrovascular system diseases. Moreover,our research would offer valuable references for the development of new drugs related to the treatment of cardio-cerebrovascular system diseases.

关 键 词：黄芪 丹参 心脑血管疾病 益气活血 

分 类 号：R285[医药卫生—中药学]